Literature DB >> 23344643

Pathways of infusate loss during convection-enhanced delivery into the putamen nucleus.

Martin L Brady1, Raghu Raghavan, Andrew Alexander, Ken Kubota, Karl Sillay, Marina E Emborg.   

Abstract

BACKGROUND: New strategies aiming to treat Parkinson's disease, such as delivery of trophic factors via protein infusion or gene transfer, depend upon localized intracerebral infusion, mainly into the putamen nucleus. Convection-enhanced delivery (CED) has been proposed as a method to improve intracerebral distribution of therapies. Yet analysis of controversial results during the clinical translation of these strategies suggests that intracerebral misdistribution of infusate may have affected the outcomes by limiting the amount of treatment into the target region.
OBJECTIVES: This study aimed to identify possible pathways of infusate loss and their relative impact in the success of targeted CED into the postcommissural ventral putamen nucleus.
METHODS: Thirteen adult macaque monkeys received intraputaminal CED infusions of 100 µl of 2.0 mM gadoteridol and bromophenol blue (0.16 mg/ml) solution at a rate of 1.0 µl/min under intraoperative magnetic resonance imaging (MRI) guidance. Quantitative maps of infusate concentration were computed at 10-min intervals throughout the procedure in a 3-Tesla MRI scanner. The fraction of tracer lost from the putamen as well as the path of loss were evaluated and quantified for each infusion.
RESULTS: All injections (total 22) were successfully placed in the ventral postcommissural putamen nucleus. Four major paths of infusate loss from the putamen were observed: overflow across putamen boundaries, perivascular flow along large blood vessels, backflow along the inserted catheter and catheter tract leakage into the vacated catheter tract upon catheter removal. Overflow loss was observed within the first 30 µl of infusion in all cases. Measurable tracer loss following the path of an artery out of the putamen was observed in 15 cases, and in 8 of these cases, the loss was greater than 10% of infusate. Backflow that exited the putamen was observed in 4 cases and led to large loss of infusate (80% in 1 case) into the corona radiata. Loss into the vacated catheter tract amounted only to a few microliters.
CONCLUSIONS: Our analysis demonstrates that after controlling for targeting, catheter type, infusion rate and infusate, the main issues during surgical planning are the identification of appropriate infusate volume that matches the target area, as well as mapping the regional vasculature as it may become a pathway for infusate loss. Most importantly, these results underscore the significance of presurgical planning for catheter placement and infusion, and the value of imaging guidance to ensure targeting accuracy.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23344643      PMCID: PMC3716010          DOI: 10.1159/000342492

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  24 in total

1.  Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study.

Authors:  Nikunj K Patel; Martin Bunnage; Puneet Plaha; Clive N Svendsen; Peter Heywood; Steven S Gill
Journal:  Ann Neurol       Date:  2005-02       Impact factor: 10.422

2.  Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor.

Authors:  John T Slevin; Greg A Gerhardt; Charles D Smith; Don M Gash; Richard Kryscio; Byron Young
Journal:  J Neurosurg       Date:  2005-02       Impact factor: 5.115

3.  Effects of the perivascular space on convection-enhanced delivery of liposomes in primate putamen.

Authors:  Michal T Krauze; Ryuta Saito; Charles Noble; John Bringas; John Forsayeth; Tracy R McKnight; John Park; Krystof S Bankiewicz
Journal:  Exp Neurol       Date:  2005-08-16       Impact factor: 5.330

4.  Striatal volume differences between non-human and human primates.

Authors:  Dali Yin; Francisco E Valles; Massimo S Fiandaca; John Forsayeth; Paul Larson; Phillip Starr; Krystof S Bankiewicz
Journal:  J Neurosci Methods       Date:  2008-09-02       Impact factor: 2.390

5.  Territories of the perforating (lenticulostriate) branches of the middle cerebral artery.

Authors:  R Donzelli; S Marinkovic; L Brigante; O de Divitiis; I Nikodijevic; C Schonauer; F Maiuri
Journal:  Surg Radiol Anat       Date:  1998       Impact factor: 1.246

6.  Convection-enhanced delivery of macromolecules in the brain.

Authors:  R H Bobo; D W Laske; A Akbasak; P F Morrison; R L Dedrick; E H Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

7.  The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain.

Authors:  Piotr Hadaczek; Yoji Yamashita; Hanna Mirek; Laszlo Tamas; Martha C Bohn; Charles Noble; John W Park; Krystof Bankiewicz
Journal:  Mol Ther       Date:  2006-05-02       Impact factor: 11.454

8.  Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial.

Authors:  William J Marks; Jill L Ostrem; Leonard Verhagen; Philip A Starr; Paul S Larson; Roy Ae Bakay; Robin Taylor; Deborah A Cahn-Weiner; A Jon Stoessl; C Warren Olanow; Raymond T Bartus
Journal:  Lancet Neurol       Date:  2008-04-02       Impact factor: 44.182

9.  Convective delivery of glial cell line-derived neurotrophic factor in the human putamen.

Authors:  Paul F Morrison; Russell R Lonser; Edward H Oldfield
Journal:  J Neurosurg       Date:  2007-07       Impact factor: 5.115

10.  Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.

Authors:  Anthony E Lang; Steven Gill; Nik K Patel; Andres Lozano; John G Nutt; Richard Penn; David J Brooks; Gary Hotton; Elena Moro; Peter Heywood; Matthew A Brodsky; Kim Burchiel; Patrick Kelly; Arif Dalvi; Burton Scott; Mark Stacy; Dennis Turner; V G Frederich Wooten; William J Elias; Edward R Laws; Vijay Dhawan; A Jon Stoessl; James Matcham; Robert J Coffey; Michael Traub
Journal:  Ann Neurol       Date:  2006-03       Impact factor: 10.422

View more
  17 in total

1.  The Relation between Catheter Occlusion and Backflow during Intraparenchymal Cerebral Infusions.

Authors:  Martin L Brady; Raghu Raghavan; Walter Block; Benjamin Grabow; Chris Ross; Ken Kubota; Andrew L Alexander; Marina E Emborg
Journal:  Stereotact Funct Neurosurg       Date:  2015-02-18       Impact factor: 1.875

2.  Real-Time Intraoperative MRI Intracerebral Delivery of Induced Pluripotent Stem Cell-Derived Neurons.

Authors:  Scott C Vermilyea; Jianfeng Lu; Miles Olsen; Scott Guthrie; Yunlong Tao; Eva M Fekete; Marissa K Riedel; Kevin Brunner; Carissa Boettcher; Viktorya Bondarenko; Ethan Brodsky; Walter F Block; Andrew Alexander; Su-Chun Zhang; Marina E Emborg
Journal:  Cell Transplant       Date:  2016-09-14       Impact factor: 4.064

Review 3.  Convection-Enhanced Delivery.

Authors:  A M Mehta; A M Sonabend; J N Bruce
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

Review 4.  Drug delivery systems, CNS protection, and the blood brain barrier.

Authors:  Ravi Kant Upadhyay
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

Review 5.  Convection-enhanced drug delivery for glioblastoma: a review.

Authors:  Randy S D'Amico; Manish K Aghi; Michael A Vogelbaum; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

6.  Neural stem cells improve intracranial nanoparticle retention and tumor-selective distribution.

Authors:  Rachael Mooney; Yiming Weng; Revathiswari Tirughana-Sambandan; Valerie Valenzuela; Soraya Aramburo; Elizabeth Garcia; Zhongqi Li; Margarita Gutova; Alexander J Annala; Jacob M Berlin; Karen S Aboody
Journal:  Future Oncol       Date:  2014-02       Impact factor: 3.404

7.  Image-guided convection-enhanced delivery into agarose gel models of the brain.

Authors:  Karl A Sillay; S Gray McClatchy; Brandon A Shepherd; Garrett T Venable; Tyler S Fuehrer
Journal:  J Vis Exp       Date:  2014-05-14       Impact factor: 1.355

8.  Titer and product affect the distribution of gene expression after intraputaminal convection-enhanced delivery.

Authors:  Marina E Emborg; Samuel A Hurley; Valerie Joers; Do P M Tromp; Christine R Swanson; Sachiko Ohshima-Hosoyama; Viktorya Bondarenko; Kyle Cummisford; Marc Sonnemans; Stephan Hermening; Bas Blits; Andrew L Alexander
Journal:  Stereotact Funct Neurosurg       Date:  2014-06-12       Impact factor: 1.875

9.  Concentration-dependent rheological properties of ECM hydrogel for intracerebral delivery to a stroke cavity.

Authors:  Andre R Massensini; Harmanvir Ghuman; Lindsey T Saldin; Christopher J Medberry; Timothy J Keane; Francesca J Nicholls; Sachin S Velankar; Stephen F Badylak; Michel Modo
Journal:  Acta Biomater       Date:  2015-08-28       Impact factor: 10.633

10.  Convection enhanced delivery to the Brain: preparing for gene therapy and protein delivery to the Brain for functional and restorative Neurosurgery by understanding low-flow neurocatheter infusions using the Alaris(®) system infusion pump.

Authors:  Karl Sillay; Angelica Hinchman; Erinc Akture; Shahriar Salamat; Gurwattan Miranpuri; Justin Williams; Dawn Berndt
Journal:  Ann Neurosci       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.